You are a helpful, respectful, and honest assistant. Always answer as helpfully as possible, while being safe. Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information.
What is 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons and explain in detail?
This article provides an update to the 2014 Atrial Fibrillation Guideline, focusing on individualizing anticoagulant therapy based on thromboembolic stroke and bleeding risks, patient values and preferences, and risk factors associated with Atrial Fibrillation. It also discusses the use of anticoagulants, Factor Xa Next Generation, interruption and bridging anticoagulation, direct-current cardioversion, beta blockers, HAS-BLED score, WOEST, PIONEER AF-PCI, RE-DUAL PCI trials, ISAR-TRIPLE trial, Bern PCI Registry, device detection of AF and atrial flutter, weight loss strategies, and warfarin.